TNFRSF8 and anaplastic large cell lymphoma: In another phase I study of anti-CD30 CAR-T cells, nine patients with relapsed refractory CD30+ HL and NHL (seven with HL and two with CD30+ anaplastic large cell lymphoma) were enrolled [82].